Horst D - Search Results

1

ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer.

Blaj C, Bringmann A, Schmidt EM, Urbischek M, Lamprecht S, Fröhlich T, Arnold GJ, Krebs S, Blum H, Hermeking H, Jung A, Kirchner T, Horst D. Blaj C, et al. Among authors: horst d. Clin Cancer Res. 2017 Jun 1;23(11):2769-2780. doi: 10.1158/1078-0432.CCR-16-1604. Epub 2016 Nov 30. Clin Cancer Res. 2017. PMID: 27903678

2

CD133 expression is an independent prognostic marker for low survival in colorectal cancer.

Horst D, Kriegl L, Engel J, Kirchner T, Jung A. Horst D, et al. Br J Cancer. 2008 Oct 21;99(8):1285-9. doi: 10.1038/sj.bjc.6604664. Epub 2008 Sep 9. Br J Cancer. 2008. PMID: 18781171 Free PMC article.

3

p16INK4a is a beta-catenin target gene and indicates low survival in human colorectal tumors.

Wassermann S, Scheel SK, Hiendlmeyer E, Palmqvist R, Horst D, Hlubek F, Haynl A, Kriegl L, Reu S, Merkel S, Brabletz T, Kirchner T, Jung A. Wassermann S, et al. Among authors: horst d. Gastroenterology. 2009 Jan;136(1):196-205.e2. doi: 10.1053/j.gastro.2008.09.019. Epub 2008 Sep 20. Gastroenterology. 2009. PMID: 18951899

4

The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer.

Horst D, Reu S, Kriegl L, Engel J, Kirchner T, Jung A. Horst D, et al. Cancer. 2009 May 15;115(10):2063-70. doi: 10.1002/cncr.24254. Cancer. 2009. PMID: 19298008 Free article.

5

CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer.

Horst D, Kriegl L, Engel J, Jung A, Kirchner T. Horst D, et al. Eur J Cancer. 2009 Jul;45(11):2034-40. doi: 10.1016/j.ejca.2009.04.004. Epub 2009 May 4. Eur J Cancer. 2009. PMID: 19403300

6

LEF-1 expression in basal cell carcinomas.

Kriegl L, Horst D, Kirchner T, Jung A. Kriegl L, et al. Among authors: horst d. Br J Dermatol. 2009 Jun;160(6):1353-6. doi: 10.1111/j.1365-2133.2009.09144.x. Epub 2009 Mar 30. Br J Dermatol. 2009. PMID: 19416246 No abstract available.

7

The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.

Horst D, Scheel SK, Liebmann S, Neumann J, Maatz S, Kirchner T, Jung A. Horst D, et al. J Pathol. 2009 Dec;219(4):427-34. doi: 10.1002/path.2597. J Pathol. 2009. PMID: 19621338

8

Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.

Horst D, Kriegl L, Engel J, Kirchner T, Jung A. Horst D, et al. Cancer Invest. 2009 Oct;27(8):844-50. doi: 10.1080/07357900902744502. Cancer Invest. 2009. PMID: 19626493

9

Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancer.

Horst D, Budczies J, Brabletz T, Kirchner T, Hlubek F. Horst D, et al. Cancer. 2009 Nov 1;115(21):4946-58. doi: 10.1002/cncr.24564. Cancer. 2009. PMID: 19658179 Free article.

10

γ-Catenin is an independent prognostic marker in early stage colorectal cancer.

Nagel JM, Kriegl L, Horst D, Engel J, Gautam S, Mantzoros CS, Kirchner T, Göke B, Kolligs FT. Nagel JM, et al. Among authors: horst d. Int J Colorectal Dis. 2010 Nov;25(11):1301-9. doi: 10.1007/s00384-010-1046-y. Epub 2010 Aug 25. Int J Colorectal Dis. 2010. PMID: 20737155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

361 results

Search Page